“International collaboration is a necessity, not a choice” when it comes to safeguarding public health, according to Emer Cooke, chair of the International Coalition of Medicines Regulatory Authorities (ICMRA), which celebrates its 10th anniversary this year.
In an interview with the Pink Sheet, Cooke explained why COVID-19 was a watershed moment for global collaboration and how ICMRA plans to build on the momentum generated by the pandemic to move the dial on collaboration in a number of areas,
Key Takeaways
-
Global regulatory collaboration is moving towards convergence.
-
COVID-19 was a game changer in driving regulatory collaboration, and ICMRA will continue developing projects started under the pandemic, including pilots on hybrid inspections and collaborative assessments of post-approval CMC changes
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?